Vericel Corp - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
VCEL Nasdaq 2836 https://vcel.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vericel Corp

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023 - Feb 28th, 2023 1:30 pm
Vericel Corporation (VCEL) Q4 Earnings Surpass Estimates - Feb 23rd, 2023 2:45 pm
Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance - Feb 23rd, 2023 12:55 pm
Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023 - Feb 9th, 2023 1:00 pm
Vericel (NASDAQ:VCEL) shareholders are still up 275% over 5 years despite pulling back 5.7% in the past week - Jan 31st, 2023 12:19 pm
Vericel Corporation (VCEL) Surges 16.3%: Is This an Indication of Further Gains? - Jan 12th, 2023 3:24 am
Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program - Jan 10th, 2023 12:55 pm
Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 - Jan 4th, 2023 1:34 pm
Vericel scores FDA approval for $142M burn treatment - Dec 30th, 2022 6:42 pm
FDA Approves MediWound's NexoBrid For Burn Treatment - Dec 30th, 2022 10:26 am
MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults - Dec 29th, 2022 6:46 pm
Vericel Announces FDA Approval of NexoBrid for the Treatment of Severe Thermal Burns in Adults - Dec 29th, 2022 6:45 pm
Vericel Third Quarter 2022 Earnings: Misses Expectations - Nov 11th, 2022 11:09 am
Vericel to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum and the Stephens Annual Investment Conference - Nov 10th, 2022 2:00 pm
Vericel Corporation (VCEL) Reports Q3 Loss, Lags Revenue Estimates - Nov 9th, 2022 2:05 pm
Vericel Reports Third Quarter 2022 Financial Results - Nov 9th, 2022 12:55 pm
Vericel to Report Third-Quarter 2022 Financial Results on November 9, 2022 - Oct 26th, 2022 12:30 pm
Here’s Why Vericel Corporation (VCEL) Shares Declined in the Second Quarter - Oct 10th, 2022 3:50 pm
Vericel to Present at the Ladenburg Thalmann Healthcare Conference - Sep 22nd, 2022 12:30 pm
Vericel to Present at the Morgan Stanley Global Healthcare and H.C. Wainwright Global Investment Conferences - Sep 6th, 2022 12:30 pm